Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/10/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Gavin D. Clark

Wrong Gavin D. Clark?

Managing Director

Phone: +44 **********  
Email: g***@***.com
Local Address:  United Kingdom
Company Description: Marlin Bioconsulting Limited was established in March 2009 by professionals with over 25 years commercial development experience and track record in the Biopharma...   more

Employment History

Board Memberships and Affiliations


  • bachelors degree , chemistry
    University of Strathclyde
75 Total References
Web References
Advisory Board Members | Scottish Lifesciences Association, 15 Dec 2015 [cached]
Gavin D Clark
Director, Lamellar Biomedical
Gavin's extensive career spanned positions in a number of major companies including Janssen, Bayer and Novartis before he became successively Global Licensing Director at GSK, and VP Business Development for Tibotec NV. In 2002 he founded Dublin based Procela Partners, with clients in the CNS, Infectious Diseases, Oncology, and Systems Biology fields. In 2009 he established Marlin Bioconsulting in UK of which he is MD. He cofounded and was CBO at MGB Biopharma, which licensed infectious diseases technology from University of Strathclyde. He continues as a Non-Executive Director of Lamellar Biomedical and heads up Commercial Development at XstalBio in Glasgow. Additionally he is both an Enterprise Partner and a member of the Life Sciences Commercial Advisory Panel at the University of Strathclyde.
Affimed Therapeutics AG - The discovery and development of next generation antibodies for the treatment of cancer and other diseases with unmet medical need., 5 June 2008 [cached]
Dr. Lang replaces Gavin D Clark who has been working as VP Business Development for the last 2 years.
Mr Clark is a founding partner at Procela Partners Limited and he will be continuing to consult for a number of early stage Biotech and Discovery Science based companies both in EU and US
Lamellar Biomedical Limited, 21 Aug 2014 [cached]
Gavin Clark - Graduate Chemist (University of Strathclyde) with 30 years experience in the industry including commercial positions at Janssen Pharmaceutica, Bayer and Novartis. More recently he was responsible for Global Infectious Diseases Licensing at GlaxoWellcome and VP Business Development at Tibotec Pharmaceuticals. In the former role he closed 8 deals including those with Otsuka, Paratek, and Pliva and was responsible for business development at Tibotec until the acquisition by Johnson & Johnson in 2002. Since then Clark has consulted in commercial roles and has - since the first multimillion dollar and company transforming deal for Acumen Pharmaceuticals in 2003 -been consistently been behind a number of fundraising, M&A and Licensing deals for his client base in USA, Asia Pacific and EU. He is a Chief Business Officer and Founder at MGB Biopharma Limited and also serves on the Scottish Life Sciences Association Advisory board.
CN Bio hires Director of Licensing - CN Bio Innovations, 6 Oct 2015 [cached]
CN Bio Innovations (CN Bio) announced today the appointment of Gavin Clark to the role of Director of Licensing. This is a new position created to facilitate the commercialization of CN Bio's novel proprietary infectious disease models.
Gavin brings with him over 35 years of experience in the pharmaceutical industry including roles as Global Licensing Manager for Anti-Infectives at Glaxo and VP Business Development at Tibotec-Virco NV.
David Scales, Chief Executive of CN Bio says "I am delighted to welcome Gavin on behalf of the CN Bio team.
"CN Bio is rare in having the potential to radically alter the speed and success of new drug regimens for our partners and millions of affected patients" said Gavin Clark. "I am excited to join CN Bio at the launch of our first-in-field technologies to the challenging antiviral therapeutic area".
Gavin joins CN Bio as a key member of the new Partner Engagement Team with immediate effect.
Affimed Therapeutics AG, Heidelberg [cached]
Affimed AG complements management team by appointing Gavin Clark as VP Business Development and Florian Fischer as Chief Financial Officer
Affimed AG, Heidelberg based recombinant antibody discovery and development company, announced today the appointment of Gavin D. Clark as Executive Vice President Business Development and Florian Fischer as Chief Financial Officer.
Gavin Clark is co-founder and principal of Procela Consultants Limited - a Dublin based Biotech Consultancy.Gavin is a chemist who has worked in various senior commercial roles at J&J, Bayer, CIBA-GEIGY, GlaxoWellcome, Phares Drug Delivery and Tibotec-Virco.Since the acquisition of the latter to J&J in 2002 he established Procela.His licensing experience encompasses Global, Regional, Drug Delivery, and Generics deals from both the big and the small side of the table.
»I am very pleased to welcome Gavin and Florian to the Management Board of Affimed AG«, said Dr. Günther CEO of Affimed. »Both bring top calibre industry skills and experience to Affimed.
Other People with the name "Clark":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.